BACKGROUND/AIMS: To construct a reference growth chart for breast-fed infants between postnatal day 2 and 11 and to assess its validity in detecting infants with hypernatraemic dehydration. The ...
Tirzepatide treatment led to a 47% greater relative reduction in weight compared with semaglutide. Topline results were announced from a phase 3b clinical trial comparing tirzepatide with semaglutide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results